CLINICAL_TRIALS
trial_result
· 2023-01-25
Clinical Trial Update: taVNS in Mild to Moderate Parkinson's Disease [NA]
Summary
Completed clinical trial of transcutaneous auricular vagus nerve stimulation (taVNS) in mild to moderate Parkinson's disease with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical University of South Carolina | Conditions: Parkinson Disease | NA | Status: COMPLETED | Results posted: 2023-01-25